Latanoprost Blumont (Latanoprost)

Latanoprost binds to FP receptors in the eye, triggering remodeling of the extracellular matrix in the ciliary body. This enhances uveoscleral outflow of aqueous humor, thereby decreasing intraocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Blumont is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the clinician’s instructions.

The safety of latanoprost in pregnancy or lactation has not been definitively established. Healthcare providers should weigh potential benefits against unknown risks and consider alternative treatments if the patient is pregnant or nursing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing schedule and comparable pressure‑reduction results, though individual response may vary.

Latanoprost Blumont should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from light and moisture, and keep the cap tightly closed when not in use to maintain product stability.

Latanoprost is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any other surface to prevent contamination.

Serious risks, though rare, include severe ocular inflammation such as uveitis, paradoxical increase in intraocular pressure, corneal edema, and allergic reactions that may cause swelling or rash around the eye. Any sudden vision changes or pain should prompt immediate medical attention.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be used with caution in individuals with active ocular infections, severe inflammation, or a history of uveitis. Consultation with an eye care professional is essential before initiating therapy.